Use of SGLT2 inhibitors after bariatric/metabolic surgery: Risk/benefit balance
André Scheen
Topics & Concepts
MedicineSurgeryType 2 Diabetes MellitusDiabetes mellitusPostprandialWeight lossComplicationObesityIntensive care medicineInternal medicineEndocrinologyBariatric Surgery and OutcomesDiet and metabolism studiesDiabetes Treatment and Management